 |
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail Molika Ashford. |
TCGA's Colorectal Cancer Analysis Marks a Number of New Drug Targets
July 18, 2012
TCGA's Colorectal Cancer Analysis Marks a Number of New Drug Targets
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Study Shows Aspirin Could Increase Survival in Colorectal Cancer Patients with PIK3CA Mutations
November 28, 2012 / Pharmacogenomics Reporter - GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - TCGA Study Shows Molecular Subtypes May Better Stratify Endometrial Cancer Patients than Histology
May 1, 2013 / Pharmacogenomics Reporter - Qiagen Expands Companion Dx Portfolio with Three Licensing Deals; Exceeds 2012 QiaSymphony Placement Target
January 7, 2013 / GenomeWeb Daily News - U Michigan Partnering with IGC to Create Sequencing-Based PGx Non-Profit
September 5, 2012 / Pharmacogenomics Reporter